⌕
Evotec · EVO · Nasdaq
Tenet 51 · Mixed
Compare
$1.56−1.27%At closeTenet 51 · Mixed
$1.56−0.02 (−1.27%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD

Evotec (EVO) Income Statement

Is this a real, growing, cash-generative business, or a story propped up by accounting?

Sources Company filings FilingsHow we compute thisNot investment advice
Business engineChoppy: revenue compounds ~7.2%/yr (FY21→FY25), net margin −13.1%. Worth your attention in FY25: Share count (+6.8%) and Capex step-up ($97.0M). Both visible in the receipts below.
The four lines that matter · FY21–FY25
Revenue ($M)▲12.2%
925.2
FY21→FY25CAGR +7.2%/yr
Net income ($M)▲40.1%
−121.5
one-off year: see footnoteCAGR —
Free cash flow ($M)▼157.2%
−107.7
capex stepped upCAGR —
Diluted EPS▲40.3%
−0.68
FY21→FY25CAGR —
What the receipts whisper · what a headline number hides
Share count
+6.8%

166.4mn → 177.8mn diluted shares since FY21. Rising share count dilutes EPS. Growth must outrun it.

Capex step-up
$97.0M

▲534% YoY in FY25, largest jump in this window; watch free-cash-flow conversion.

Returns vs FCF
n/m

$1.8M returned vs $−107.7M of FCF in FY25. Free cash flow was negative, so returns were funded from the balance sheet rather than from cash generation.

What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)925.2Revenue−791.2COGS134.0Gross profit−44.0R&D−206.5SG&A−65.2Op income−56.3Tax & other−121.5Net income

-13¢ of every revenue dollar becomes profit. The biggest cost lever is COGS.

Margin trend · direction beats level Gross Operating Net
403020100%FY21FY25

Over this window: gross 24.5% → 14.5%. Net margin -13.1% is below the sector median.

The receipt · income statement · FY21–FY25 USD millions except per-share & ratios · hover a line for its definition
USD millions except per-share & ratios
Line itemFY25FY24FY23FY22FY21YoYCAGR 21→25
Revenue & profitability
Revenue
925.2824.9864.4803.9699.5▲12.2%+7.2%
Cost of revenue
791.2706.0670.8617.7528.0▲12.1%+10.6%
Gross profit
134.0118.9193.6186.2171.5▲12.7%−6.0%
Research & development
44.052.675.882.081.7▼16.4%−14.3%
Selling, general & admin
206.5194.8187.6167.1119.3▲6.0%+14.7%
Total operating expenses
199.3209.6246.2163.9125.1▼4.9%+12.3%
Operating incomefeeds ROC rank
−65.2−90.7−52.622.346.4▲28.1%—
Other income, net
−36.6−110.1−36.6−187.0221.8——
Pretax income
−101.8−200.8−89.2−164.7268.2▲49.3%—
Income tax
19.72.23.723.224.3▲803.5%−5.2%
Net incomePiotroski ROA ✕feeds Buffett Quality owner earnings
−121.5−203.0−92.8−187.9243.9▲40.1%—
Per share
Diluted EPSbuyback-sensitive
−0.68−1.14−0.52−1.061.47▲40.3%—
Diluted shares (mn)
177.78177.30176.92176.67166.41▲0.3%+1.7%
Margins
Gross margin6th pct in Healthcare
14.5%14.4%22.4%23.2%24.5%▲0.1pp−10.0pp
Operating margin
−7.1%−11.0%−6.1%2.8%6.6%▲3.9pp−13.7pp
Net margin38th pct in Healthcare
−13.1%−24.6%−10.7%−23.4%34.9%▲11.5pp−48.0pp
FY21 effective tax rate was 9% vs a −4% norm for this window, likely a one-time item; see the filing.FY22 effective tax rate was −14% vs a −4% norm for this window, likely a one-time item; see the filing.
FY19 – FY20 · 2 more years
Unlock the full history →
2 more years of statements and CSV export are on Premium.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
Annual report filed 2026-04-08 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.

What was Evotec's revenue last fiscal year?

Evotec reported revenue of $925.2M in fiscal 2025, up 12.2% from fiscal 2024.

What was Evotec's net income?

Evotec reported net income of −$121.5M in fiscal 2025, a net margin of −13.1%.

Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.